Towa Pharmaceutical Co., Ltd.
[Towa Pharmaceutical] Notice Regarding Controlling Shareholder ｜ June 24, 2026
Towa Pharmaceutical discloses that its parent company, Yoshida Office Co., Ltd., owns 40.85% of voting rights, and CEO Isao Yoshida also serves as a director of the company. The company states that its operational independence is maintained.
Key Figures
- Voting Rights Ownership Ratio (%): 40.85
- Consolidated Target Portion: 4.90
- Voting Rights Ownership Ratio of Controlling Shareholder (%): 45.75
AI要約
Matters Concerning the Controlling Shareholder
Towa Pharmaceutical discloses that Yoshida Office Co., Ltd. owns 40.85% of voting rights, and CEO Isao Yoshida also serves as a director of the company. Yoshida Office is a related company and states that it does not impact business activities. The company has no transactions with its parent company or affiliates and maintains independence.
Future Outlook and Impact on Shareholders
This document aims to disclose information regarding the controlling shareholder and does not detail specific business performance or future outlook. For investors, it provides important information regarding the ownership ratio of the controlling shareholder and the company's independence.
Towa Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
